PCOS and Insulin Resistance: How It Affects Your Weight

REVIEWED BY

William Maish, MD MBA MPH

Clinical Product Lead

Published

Last updated

Key takeaway:

Insulin resistance forces the pancreas to overproduce insulin, which promotes abdominal fat storage and simultaneously drives excess androgen production in the ovaries while suppressing SHBG — increasing free testosterone. This creates a self-reinforcing cycle where insulin resistance worsens androgens and androgens worsen insulin resistance. Improving insulin sensitivity is the central lever for both weight and hormonal outcomes in PCOS.

Read more →

Understand what your pcos results really mean

See your biomarkers in context with a comprehensive panel.

  • CLIA-certified labs
  • HIPAA compliant
  • Personalized health protocol
Book your test

You're eating less, moving more, and the scale won't budge. Or worse, it's climbing. If you have polycystic ovary syndrome, this isn't a failure of willpower. It's a metabolic problem with a specific mechanism: insulin resistance. When your cells stop responding to insulin the way they should, your body compensates by making more. That extra insulin doesn't just manage blood sugar. It signals fat storage, raises androgen levels, and makes weight loss feel nearly impossible. Understanding how insulin resistance fuels PCOS weight gain is the first step toward addressing it.

What insulin resistance actually does in PCOS

Insulin is a hormone that helps glucose move from your bloodstream into your cells, where it's used for energy. In insulin resistance, your cells become less responsive to insulin's signal. Your pancreas compensates by producing more insulin to get the job done. This state of elevated insulin, called hyperinsulinemia, is where the metabolic trouble begins.

The excess insulin doesn't just affect blood sugar. It directly stimulates the ovaries to produce more androgens, particularly testosterone. Higher androgen levels disrupt ovulation, contribute to symptoms like acne and excess hair growth, and interfere with the body's ability to regulate fat storage. Insulin also reduces the production of sex hormone-binding globulin (SHBG), a protein that normally binds to testosterone and keeps it inactive. With less SHBG, more free testosterone circulates, amplifying the hormonal imbalance.

This creates a cycle: insulin resistance raises insulin, insulin raises androgens, and androgens worsen insulin resistance. The result is a metabolic environment that favors weight gain and makes weight loss significantly harder.

Join 150,000+ others building better health

Get the science behind better health, every week.

By clicking “Subscribe” you agree to our Terms of Service and Privacy Policy.

How insulin resistance affects metabolism, hormones, and fat storage

Metabolic rate and energy expenditure

Insulin resistance slows your metabolic rate by impairing how efficiently your body uses glucose for energy. When cells resist insulin, glucose stays in the bloodstream longer, and your body shifts toward storing energy as fat rather than burning it. This metabolic slowdown means you burn fewer calories at rest, even if your activity level hasn't changed.

Hormonal disruption and androgen excess

Elevated insulin stimulates the ovaries to overproduce androgens, particularly testosterone. At the same time, insulin suppresses SHBG production in the liver, leaving more testosterone unbound and biologically active. This hormonal imbalance disrupts ovulation, contributes to irregular periods, and drives symptoms like hirsutism and acne. High androgens also promote fat accumulation in the abdominal area, a pattern associated with greater metabolic risk.

Fat storage and body composition

Insulin is a fat-storage hormone. When insulin levels are chronically elevated, your body preferentially stores fat, particularly visceral fat around the abdomen. This type of fat is metabolically active and releases inflammatory molecules that further worsen insulin resistance. Women with PCOS often experience weight gain concentrated in the midsection, even when total body weight remains stable. This shift in body composition increases the risk of metabolic syndrome, cardiovascular disease, and type 2 diabetes.

Appetite regulation and cravings

Insulin resistance disrupts the signaling of leptin, a hormone that regulates hunger and satiety. When leptin signaling is impaired, your brain doesn't receive the message that you're full, leading to increased appetite and cravings, particularly for carbohydrates. This makes it harder to maintain a caloric deficit, even when you're consciously trying to eat less.

Why PCOS makes insulin resistance worse

Insulin resistance in PCOS is driven by a combination of genetic predisposition, hormonal imbalances, inflammation, and lifestyle factors. Genetics play a role in how your body processes insulin and stores fat. If you have a family history of type 2 diabetes or metabolic syndrome, your risk of developing insulin resistance is higher.

Excess body weight, particularly visceral fat, worsens insulin resistance by releasing inflammatory cytokines that interfere with insulin signaling. However, insulin resistance can occur in lean women with PCOS as well, suggesting that hormonal factors independent of weight contribute to the condition. Elevated androgens themselves impair insulin sensitivity, creating a feedback loop where high testosterone worsens insulin resistance, and high insulin raises testosterone.

Chronic low-grade inflammation is another driver. Women with PCOS often have elevated levels of C-reactive protein (CRP) and other inflammatory markers, which interfere with insulin receptor function. Dietary patterns high in refined carbohydrates and added sugars exacerbate insulin resistance by causing repeated spikes in blood glucose and insulin. Over time, this constant demand on the pancreas leads to worsening insulin resistance and, in some cases, progression to prediabetes or type 2 diabetes.

Why weight loss is harder with PCOS and insulin resistance

Weight loss in PCOS is harder because the metabolic environment actively resists it. High insulin levels promote fat storage and inhibit fat breakdown, a process called lipolysis. When insulin is elevated, your body stays in storage mode rather than burning stored fat for energy. This makes it difficult to lose weight even in a caloric deficit.

Hormonal imbalances compound the problem. Elevated androgens shift body composition toward more fat and less muscle. Muscle tissue is metabolically active and burns more calories at rest, so losing muscle mass further slows your metabolic rate. Women with PCOS also experience greater metabolic adaptation during weight loss, meaning their bodies reduce energy expenditure more than expected for the amount of weight lost. This adaptive response makes it harder to sustain weight loss over time.

Individual variation in insulin sensitivity, androgen levels, and inflammatory markers means that the same dietary or exercise intervention produces different results in different women. Some women with PCOS respond well to moderate carbohydrate restriction, while others see better results with higher fiber intake and balanced macronutrients. Tracking biomarkers like fasting insulin, triglyceride-glucose index, and leptin can help identify which approach is working for your specific metabolic profile.

Test 100+ biomarkers from home

One blood draw. A full picture of your health, explained in plain language.

Book your test

Using biomarkers to guide your PCOS approach

Measuring insulin resistance and metabolic health over time gives you a clearer picture of what's working. Fasting insulin is one of the most direct markers of insulin resistance. While there is no universally agreed clinical cutoff, many practitioners consider levels above 10 µIU/mL as a potential indicator of insulin resistance, even if fasting glucose is still normal. The threshold varies by population and assay method. Hemoglobin A1c reflects average blood sugar over the past three months and helps identify prediabetes or diabetes risk. The triglyceride-glucose index, calculated from fasting triglycerides and glucose, is a validated marker of insulin resistance that correlates well with more complex tests.

Other useful markers include adiponectin, a hormone produced by fat cells that improves insulin sensitivity. Lower adiponectin levels are associated with greater insulin resistance. Leptin levels reflect both fat mass and leptin resistance. High leptin with persistent hunger suggests impaired leptin signaling. Tracking testosterone, SHBG, and the free androgen index helps assess hormonal balance and response to treatment.

Monitoring these markers every three to six months allows you to see whether dietary changes, exercise, or other interventions are improving insulin sensitivity and metabolic health. Directionality matters more than any single value. If fasting insulin is trending down and adiponectin is rising, you're moving in the right direction, even if weight loss is slower than expected.

If you're managing PCOS and insulin resistance, Superpower's 100+ biomarker panel can show you exactly where your metabolism and hormones stand, so you're adjusting based on data, not guesswork.

Frequently Asked Questions

References

  1. Anagnostis P, Paparodis RD, Bosdou JK, Bothou C, Macut D, Goulis DG, Livadas S (2021). Risk of type 2 diabetes mellitus in polycystic ovary syndrome is associated with obesity: a meta-analysis of observational studies. *Endocrine*, *74*(2), 245-253. https://doi.org/10.1007/s12020-021-02801-2
  2. Diamanti-Kandarakis E, Dunaif A (2012). Insulin resistance and the polycystic ovary syndrome revisited: An update on mechanisms and implications. *Endocrine Reviews*, *33*(6), 981-1030. https://doi.org/10.1210/er.2011-1034
  3. Zheng, S.-H., Du, D.-F., Li, X.-L. (2017). Leptin levels in women with polycystic ovary syndrome: A systematic review and a meta-analysis. *Reproductive Sciences*, *24*(5), 656-670. https://doi.org/10.1177/1933719116670265
  4. Scragg J, Hobson A, Willis L, Taylor KS, Dixon S, Jebb SA (2024). Effect of weight loss interventions on the symptomatic burden and biomarkers of polycystic ovary syndrome: A systematic review of randomized controlled trials. *Annals of Internal Medicine*, *177*(12), 1664-1674. https://doi.org/10.7326/M23-3179
  5. Kim, C.-H., Lee, S.-H. (2022). Effectiveness of lifestyle modification in polycystic ovary syndrome patients with obesity: A systematic review and meta-analysis. *Life*, *12*(2), 308. https://doi.org/10.3390/life12020308

Led by doctors with 40 years of health and longevity expertise

Dr. Anant Vinjamoori

Dr. Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Dr. Leigh Erin Connealy

Dr. Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Dr. Robert Lufkin

Dr. Robert Lufkin, MD

Physician & UCLA Medical School Professor, NYT bestselling author

Dr. Abe Malkin

Dr. Abe Malkin, MD

Founder & Medical Director of Concierge MD

Membership 1
1 / 4

Your membership starts here

Annual 100+ biomarker panel

  • Data dashboard and digital twin
  • Upload past labs and connect wearables
  • Personalized health protocol
  • 24/7 care team access
  • AI companion for all health questions
  • Marketplace with additional solutions
$199
/year*Billed annually
Get started
HSA/FSA eligibleCancel anytimeResults in a week

*Pricing may vary for members in New York and New Jersey